Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | WDR5 | P61964 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | ENGASE | Q8NFI3 | 3/20 | 0.60 |
| ▸ | SARM1 | Q6SZW1 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | ATP4A | P20648 | 3/20 | 0.60 |
| ▸ | ATP4B | P51164 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,4-Butanediol SCHEMBL2365476 | 0.95 | CYP2C9 (0.55) | CYP2C9MAPTWDR5KMT2AENGASE | |
| Propylene Glycol SCHEMBL2364761 | 0.93 | CYP2C9 (0.54) | CYP2C9MAPTWDR5KMT2AENGASE | |
| Ethylene Glycol SCHEMBL2364760 | 0.92 | CYP2C9 (0.53) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL2365467 | 0.92 | CYP2C9 (0.52) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL2365470 | 0.92 | CYP2C9 (0.52) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL2365190 | 0.90 | CYP2C9 (0.51) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL5437937 | 0.85 | KMT2A (0.54) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL106666 | 0.85 | CYP2C9 (0.63) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL30052062 | 0.85 | CYP2C9 (0.63) | CYP2C9MAPTWDR5KMT2AENGASE | |
| SCHEMBL5414007 | 0.85 | KMT2A (0.60) | CYP2C9MAPTWDR5KMT2AENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011098938-A1 | NOVEL SOLVATE OF DEXLANSOPRAZOLE | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2011-08-18 | — | — | WO | claimed |
| EP-4558514-A2 | AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY | New York University (US) | 2025-05-28 | — | — | EP | disclosed |
| WO-2024020574-A2 | AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY | NEW YORK UNIVERSITY (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-2663306-A1 | POLYMORPHS OF DEXLANSOPRAZOLE SALTS | Hetero Research Foundation (IN) | 2013-11-20 | — | — | EP | disclosed |
| WO-2012095859-A1 | POLYMORPHS OF DEXLANSOPRAZOLE SALTS | HETERO RESEARCH FOUNDATION (IN) | 2012-07-19 | — | — | WO | disclosed |
| WO-2011098938-A1 | NOVEL SOLVATE OF DEXLANSOPRAZOLE | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2011-08-18 | — | — | WO | disclosed |
| WO-2011098938-A1 | NOVEL SOLVATE OF DEXLANSOPRAZOLE | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2011-08-18 | — | — | WO | disclosed |
| EP-2222663-A1 | A PROCESS FOR PREPARATION OF STABLE AMORPHOUS R-LANSOPRAZOLE | Watson Pharma Private Limited (IN) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009087672-A1 | A PROCESS FOR PREPARATION OF STABLE AMORPHOUS R-LANSOPRAZOLE | Watson Pharma Private Limited (IN) | 2009-07-16 | — | — | WO | disclosed |
| WO-2007026188-A1 | PROCESS FOR THE MANUFACTURE OF ANTIULCERATIVES | WOCKHARDT LIMITED (IN) | 2007-03-08 | — | — | WO | disclosed |
| WO-2004098610-A1 | BENZOTRIAZEPINE DERIVATIVES AND THEIR USE AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 2004-11-18 | — | — | WO | disclosed |
| EP-1467987-A1 | PREPARATION OF LANSOPRAZOLE AND RELATED COMPOUNDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-10-20 | — | — | EP | disclosed |
| EP-1368338-A4 | METHOD OF PREPARING LANSOPRAZOLE AND ITS INTERMEDIATE | HANSOL CHEMIENCE CO LTD (KR) | 2004-09-15 | — | — | EP | disclosed |
| WO-2004011455-A1 | PREPARATION OF LANSOPRAZOLE AND RELATED COMPOUNDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-02-05 | — | — | WO | disclosed |
| EP-1368338-A1 | METHOD OF PREPARING LANSOPRAZOLE AND ITS INTERMEDIATE | Chemtech Research Incorporation (KR) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002074766-A1 | METHOD OF PREPARING LANSOPRAZOLE AND ITS INTERMEDIATE | CHEMTECH RESEARCH INCORPORATION (KR) | 2002-09-26 | — | — | WO | disclosed |
| EP-1185254-A2 | ORALLY ADMINISTERED PHARMACEUTICAL FORMULATIONS OF BENZIMIDAZOLE DERIVATIVES AND THE METHOD OF PREPARING THE SAME | Carlsbad Technology Inc (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2001052816-A2 | ORALLY ADMINISTERED PHARMACEUTICAL FORMULATIONS OF BENZIMIDAZOLE DERIVATIVES AND THE METHOD OF PREPARING THE SAME | CARLSBAD TECHNOLOGY, INC. (US) | 2001-07-26 | — | — | WO | disclosed |
| EP-0696921-A1 | VETERINARY COMPOSITION CONTAINING A PROTON PUMP INHIBITOR | Astra Aktiebolag (SE) | 1996-02-21 | — | — | EP | disclosed |
| WO-1994025070-A1 | VETERINARY COMPOSITION CONTAINING A PROTON PUMP INHIBITOR | ASTRA AKTIEBOLAG (SE) | 1994-11-10 | — | — | WO | disclosed |